Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;4(3):327-33.

Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial

Affiliations

Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial

Elahe Mesdaghinia et al. Int J Prev Med. 2013 Mar.

Abstract

Background: Few studies have been done on the use of metformin in pregnancy and their results were not similar, therefore this research is performed to compare neonatal outcomes of metformin and insulin in the treatment of gestational diabetes.

Methods: In this prospective randomized trial, 200 pregnant women within their 24(th) to 34(th) weeks of gestation with gestational diabetes, single fetus pregnancy, and in need of hyperglycemia treatment were entered and grouped as either metformin or insulin. Data related to maternal and neonatal outcomes were recorded and analyzed.

Results: Considering data recorded of HbA1c at the beginning of pregnancy, pregnancy induced hypertension, preeclampsia, birth weight, dystocia, first and 5(th) min APGAR, neonatal sepsis, rout of delivery, liver function tests of neonate, hypoglycemia, anomaly, and still birth, there were no significant statistical differences between groups. The end pregnancy HbA1c, maternal weight gain during pregnancy, preterm labor, neonatal jaundice, respiratory distress and hospitalization of infants were higher in insulin group.

Conclusions: Considering data from this study, metformin is efficient to control hyperglycemia in pregnancy. It is suggested performing more studies to evaluate long term side effects of metformin in pregnancy with higher sample size and longer follow-up of newborns.

Keywords: Hemoglobin A1c; glucose tolerance test; hyperglycemia; pregnancy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

Figures

Figure 1
Figure 1
flow diagram of the progress through the phases of parallel randomised trial of two groups

References

    1. Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes (Review) Cochrane Database Syst Rev. 2009;3:1–57. - PMC - PubMed
    1. Canningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Catherine YS. Williams Obstetrics. 23rd ed. New York: McGraw-Hill; 2010. pp. 1104–21.
    1. Gibbs RS, Karlan BY, Haney AF, Nygaard IE. Danforth's Obstetrics and Gynecology. 10th ed. Philadelphia: Lippincott Williams and Wilkins; 2008. pp. 247–51.
    1. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort. Diabetes Care. 2005;28:579–84. - PubMed
    1. Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynaecol Clin North Am. 2007;34:173–99. - PMC - PubMed

LinkOut - more resources